Dr. Reddy's, Ivax to Appeal Zyprexa Patent Decision

Law360, New York (April 18, 2005, 12:00 AM EDT) -- Generic drug makers Dr. Reddy's Laboratories and Ivax have vowed to appeal last week's ruling by an Indiana federal court that upheld Eli Lilly's patent on the blockbuster schizophrenia drug Zyprexa.

“We are disappointed by the court decision and will appeal the decision to the Federal Circuit. Despite today's adverse ruling, our strategy remains unchanged and we continue to make consistent progress toward building a sustainable generics business in the U.S.,” GV Prasad, CEO of Dr. Reddy's, said in a statement after the decision.

Ivax struck...
To view the full article, register now.